Northwest Biotherapeutics (NWBO.OB) Reports Stimulating Follow-Up Data to Clinical Trials for its Brain Cancer Treatment
Northwest Biotherapeutics, Inc. (www.nwbio.com) today (Tuesday, August 3) reported some excellent long-term follow-up data related to previous Phase I and…